sertraline hydrochloride
- Product NDC
- 47781-962
- 11-digit product format
- 477810962
- Labeler code
- 47781
- Product ID
- 47781-962_6dc518cc-d3cf-5888-2b4e-90d598afac58
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- sertraline hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Alvogen, Inc.
- Application
- NDA215133
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2025-09-18
- Substance
- SERTRALINE HYDROCHLORIDE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| UTI8907Y6X | SERTRALINE HYDROCHLORIDE | 79559-97-0 | SERTRALINE HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 47781-962-30 | 47781096230 | 30 CAPSULE in 1 BOTTLE (47781-962-30) | 30 capsule | 2025-09-22 | No | No | Historical |